Comparisons of clinical characteristics, prognosis, epidemiological factors, and genetic susceptibility between HER2-low and HER2-zero breast cancer among Chinese females.

Lu ZhengYunmeng ZhangZhipeng WangHuan WangChunfang HaoChenyang LiYanrui ZhaoZhangyan LyuFangfang SongKexin ChenYubei HuangFengju Song

Published in: Cancer medicine (2023)

HER2-low BC should deserve more attention than HER2-zero BC, especially in HR-negative BC, due to larger proportion, less clinical heterogeneity, better prognosis, and less susceptibility to risk factors.

Keyphrases

risk factors
working memory
genome wide
single cell
gene expression
dna methylation
childhood cancer